Skip to main content
Matthew Ferris, MD, Radiation Oncology, Baltimore, MD

MatthewJeffreyFerrisMD

Radiation Oncology Baltimore, MD

Head & Neck, Skin Cancer, Thoracic Cancer

Head/Neck/Thoracic/Skin Radiation Oncology │ Medical Director, Maryland Proton Treatment Center │ Department of Radiation Oncology, University of Maryland School of Medicine

Overview of Dr. Ferris

Dr. Matthew Ferris is a radiation oncologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and University of Maryland Upper Chesapeake Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 2 years. He is one of 51 doctors at University of Maryland Medical Center and one of 12 doctors at University of Maryland Upper Chesapeake Medical Center who specialize in Radiation Oncology. He has more than 30 publications and over 300 citings.

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineResidency, Radiation Oncology, 2014 - 2019
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2014
  • Loyola University Maryland
    Loyola University MarylandBS, Biology, Summa Cum Laude; Business Minor; English Minor, 2006 - 2010

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2019 - 2026
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Inductee Phi Beta Kappa Society, 2009
  • Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

Journal Articles

  • Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with Radiotherapy  
    Gabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer

Authored Content

  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018

Press Mentions

  • Cancer treatment advances are helping patients and dropping death rates
    Cancer treatment advances are helping patients and dropping death ratesFebruary 17th, 2020

Professional Memberships